ligands acting on targets

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

Product Application:(R)-MG132 has been used in ubiquitination assay and is used as a proteasome inhibitor.

(R)-MLN-4760, the R-enantiomer of MLN-4760, is an ACE2 inhibitor, with an IC 50 of 8.4 μM. (R)-MLN-4760 is the less active isomerIn Vitro(R)-MLN-4760 (compound 16RS) is the less active isomer of MLN-4760. MCE has not independently confirmed the

(R)-MLN-4760, the R-enantiomer of MLN-4760, is an ACE2 inhibitor, with an IC 50 of 8.4 μM. (R)-MLN-4760 is the less active isomerIn Vitro(R)-MLN-4760 (compound 16RS) is the less active isomer of MLN-4760. MCE has not independently confirmed the

(R)-MLN-4760, the R-enantiomer of MLN-4760, is an ACE2 inhibitor, with an IC 50 of 8.4 μM. (R)-MLN-4760 is the less active isomerIn Vitro(R)-MLN-4760 (compound 16RS) is the less active isomer of MLN-4760. MCE has not independently confirmed the

(R)-MLN-4760, the R-enantiomer of MLN-4760, is an ACE2 inhibitor, with an IC 50 of 8.4 μM. (R)-MLN-4760 is the less active isomerIn Vitro(R)-MLN-4760 (compound 16RS) is the less active isomer of MLN-4760. MCE has not independently confirmed the

(R)-MLN-4760, the R-enantiomer of MLN-4760, is an ACE2 inhibitor, with an IC 50 of 8.4 μM. (R)-MLN-4760 is the less active isomerIn Vitro(R)-MLN-4760 (compound 16RS) is the less active isomer of MLN-4760. MCE has not independently confirmed the